Rhinitis News and Research

RSS

Rhinitis, commonly known as a runny nose, is the medical term describing irritation and inflammation of some internal areas of the nose. The primary symptom of rhinitis is nasal dripping. It is caused by chronic or acute inflammation of the mucous membrane of the nose due to viruses, bacteria or irritants.

Long COVID significantly affects children for up to 36 months, vaccines offer crucial protection

Study reveals the significant and lasting impact of long COVID on children, emphasizing the protective role of vaccines and the increased risk of autoimmune disorders.

8 Sep 2024

Insilico Medicine partners with Inimmune to advance immunotherapeutic discovery

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced that the company has achieved a groundbreaking collaboration with Inimmune, which will utilize Chemistry42, Insilico's proprietary generative artificial intelligence (AI) technology to accelerate the discovery and development of next-generation immunotherapeutics.

5 Sep 2024

Intranasal vaccine shows broad SARS-CoV-2 variant protection

Study demonstrates that a single-dose intranasal live-attenuated vaccine, CDO-7N-1, provides broad protection against SARS-CoV-2 and its variants by inducing potent immune responses, including neutralizing antibodies and T-cell activity, in animal models.

1 Sep 2024

How does the season of birth influence the risk of asthma and allergic rhinitis?

Finnish researchers report that season of birth likely impacts an individual’s future risk of developing airway allergy and related diseases.

20 Aug 2024

Finnish study links autumn and winter births to higher rates of asthma and allergic rhinitis

Being born in autumn or winter is associated with asthma and allergic rhinitis in Finland, a new registry-based study shows.

14 Aug 2024

Does type 1 diabetes affect taste and flavor recognition?

Type 1 diabetes patients show reduced taste and flavor perception, affecting food preferences and quality of life. This highlights the need for further research into the sensory changes in T1D.

7 Aug 2024

Study suggests limiting oral corticosteroid use to 90 days reduces adverse effects in atopic dermatitis patients

Researchers evaluated the association between long-term oral corticosteroid use and adverse events in adult patients with atopic dermatitis.

24 Jul 2024

Chronic Urticaria: Addressing unmet needs, emerging therapies, and advances in personalized treatment approaches

Emerging personalized treatment approaches for chronic urticari.

16 Jul 2024

“G900” gene enhancers may play a pivotal role in asthma-associated inflammation

Type-2 helper T (Th2) cells play intricate roles in the inflammatory response underlying asthma. Elevated levels of the protein GATA3 stimulate the maturation of these cells. Consequently, gene regions known as enhancers, which enhance the expression of the GATA3 gene, have been implicated in asthma-associated inflammation.

26 Jun 2024

Study links gene regulation to allergic airway inflammation

Asthma patients experience respiratory distress due to allergens like house dust mites or pollen. However, the various triggers for asthma share a common pathway involving the release of proteins called type-2 cytokines by Type-2 helper T (Th2) cells and group-2 innate lymphoid cells (ILC2s). Both Th2 and ILC2 require high amounts of GATA-binding protein 3 (GATA3) for their maturation.

25 Jun 2024

USC study unveils iron as key driver of lung inflammation in allergic asthma

New USC research shows that iron serves as a gas pedal driving certain immune cells that cause inflammation in the lungs during an allergic asthma attack – and blocking or limiting iron may reduce the severity of symptoms.

8 May 2024

Study investigates the potential effects of neonatal vitamin D on eczema up to adulthood

Australian researchers find that higher neonatal vitamin D levels are associated with lower odds of early-onset persistent eczema but an increased risk of early-onset resolving eczema in children up to age 25.

30 Apr 2024

Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses

Whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection influences children's asthma risk.

16 Apr 2024

SARS-COV-2 infection not linked to increased risk of asthma development in pediatric patients

In the wake of the COVID-19 pandemic, many families worried about the long-term effects posed by the SARS-COV-2 virus.

13 Apr 2024

Alarmin molecule identified as therapeutic target for allergic respiratory diseases

One of the molecules responsible for triggering the inflammation that causes allergic respiratory diseases, such as asthma and allergic rhinitis, has just been discovered by scientists from the CNRS, Inserm and the Université Toulouse III – Paul Sabatier.

12 Apr 2024

Rhinitis News and Research

Further Reading

Long COVID significantly affects children for up to 36 months, vaccines offer crucial protection

Insilico Medicine partners with Inimmune to advance immunotherapeutic discovery

Intranasal vaccine shows broad SARS-CoV-2 variant protection

How does the season of birth influence the risk of asthma and allergic rhinitis?

Finnish study links autumn and winter births to higher rates of asthma and allergic rhinitis

Does type 1 diabetes affect taste and flavor recognition?

Study suggests limiting oral corticosteroid use to 90 days reduces adverse effects in atopic dermatitis patients

Chronic Urticaria: Addressing unmet needs, emerging therapies, and advances in personalized treatment approaches

“G900” gene enhancers may play a pivotal role in asthma-associated inflammation

Study links gene regulation to allergic airway inflammation

USC study unveils iron as key driver of lung inflammation in allergic asthma

Study investigates the potential effects of neonatal vitamin D on eczema up to adulthood

Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses

SARS-COV-2 infection not linked to increased risk of asthma development in pediatric patients

Alarmin molecule identified as therapeutic target for allergic respiratory diseases

New study reveals increased risk of allergic diseases after COVID-19 infection

Food allergies' broad impact on quality of life demands greater awareness

Omalizumab boosts tolerance to multiple food allergies, study finds

Omalizumab shows promise in preventing food allergy reactions in children, study finds

COVID-19's lasting impact on smell and brain health unveiled

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News